File Download
  Links for fulltext
     (May Require Subscription)

Conference Paper: Leucine-rich repeat kinase-2 (LRRK2) R1441G knockin mice are more susceptible to rotenone toxicity

TitleLeucine-rich repeat kinase-2 (LRRK2) R1441G knockin mice are more susceptible to rotenone toxicity
Authors
KeywordsMedical sciences
Psychiatry and neurology
Issue Date2014
PublisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/76507419
Citation
The 18th International Congress of Parkinson’s Disease and Movement Disorders, Stockholm, Sweden, 8-12 June 2014. In Movement Disorders, 2014, v. 29 n. S1 How to Cite?
AbstractOBJECTIVE: To assess the susceptibility of LRRK2 R1441G knockin mice against (1) striatal dopamine (DA) uptake deficit, (2) locomotor inactivity and, (3) dopaminergic neuronal cell death, as induced by rotenone (mitochondrial complex-I inhibitor). BACKGROUND: LRRK2 mutations are the commonest genetic risk in Parkinson's disease (PD). LRRK2 is linked to synapse functions. However, the pathogenic mechanism of LRRK2 mutation in striatal DA homeostasis and mitochondria dysfunction is unknown. METHODS: Cell viability of primary DA neurons from R1441G knockin mice and their wild-type littermates were compared after rotenone exposure. Total [3H]-DA uptake in isolated striatal synaptosomes incubated with rotenone, and the locomotor activity in open-field test after chronic (20 weeks) oral gavage of rotenone were also assessed. RESULTS: Without rotenone, R1441G mutant mice show no overt phenotype. However, synaptosomes from young (3-month-old) mutant mice exhibited lower DA uptake when incubated with rotenone (100nM), compared with wild-type controls. Number of tyrosine hydroxylase (TH)-positive neurons in mutant culture after rotenone exposure (5nM) was significantly lower. Also, chronic exposure to rotenone (5mg/kg, twice per week orally) for 20 weeks caused significantly lower locomotor activity in mutant mice compared with the wild-type controls. CONCLUSIONS: Similar to R1441C [1], LRRK2 R1441G mutant mice show no overt phenotype. However, R1441G mutant synaptosomes were more vulnerable to rotenone toxicity as shown by lower DA uptake, indicating that R1441G mutation contributes to mitochondrial dysfunction-induced synaptic dysfunction. Re-uptake of extracellular DA requires mitochondrial ATP for synaptic recycling. Uptake deficits associated with LRRK2 mutation may adversely affects striatal neuronal survival and locomotor activity as observed in our mutant mice. This differential susceptibility against rotenone toxicity of the mutant mice suggests that LRRK2 R1441G mutation may be a predisposing genetic factor in synaptic energy deficiency leading to early striatal synaptic dysfunction [2], and later nigrostriatal DA cell death in LRRK2-associated PD.
DescriptionThis journal suppl. entitled: Supplement: Abstracts of the Eighteenth International Congress of Parkinson's Disease and Movement Disorders / Poster Presentation
Persistent Identifierhttp://hdl.handle.net/10722/198607
ISSN
2015 Impact Factor: 6.01
2015 SCImago Journal Rankings: 2.733

 

DC FieldValueLanguage
dc.contributor.authorLiu, Hen_US
dc.contributor.authorHo, WLen_US
dc.contributor.authorTse, HMen_US
dc.contributor.authorKung, MHWen_US
dc.contributor.authorZhou, Zen_US
dc.contributor.authorRamsden, DBen_US
dc.contributor.authorHo, SLen_US
dc.date.accessioned2014-07-07T08:11:01Z-
dc.date.available2014-07-07T08:11:01Z-
dc.date.issued2014en_US
dc.identifier.citationThe 18th International Congress of Parkinson’s Disease and Movement Disorders, Stockholm, Sweden, 8-12 June 2014. In Movement Disorders, 2014, v. 29 n. S1en_US
dc.identifier.issn0885-3185-
dc.identifier.urihttp://hdl.handle.net/10722/198607-
dc.descriptionThis journal suppl. entitled: Supplement: Abstracts of the Eighteenth International Congress of Parkinson's Disease and Movement Disorders / Poster Presentation-
dc.description.abstractOBJECTIVE: To assess the susceptibility of LRRK2 R1441G knockin mice against (1) striatal dopamine (DA) uptake deficit, (2) locomotor inactivity and, (3) dopaminergic neuronal cell death, as induced by rotenone (mitochondrial complex-I inhibitor). BACKGROUND: LRRK2 mutations are the commonest genetic risk in Parkinson's disease (PD). LRRK2 is linked to synapse functions. However, the pathogenic mechanism of LRRK2 mutation in striatal DA homeostasis and mitochondria dysfunction is unknown. METHODS: Cell viability of primary DA neurons from R1441G knockin mice and their wild-type littermates were compared after rotenone exposure. Total [3H]-DA uptake in isolated striatal synaptosomes incubated with rotenone, and the locomotor activity in open-field test after chronic (20 weeks) oral gavage of rotenone were also assessed. RESULTS: Without rotenone, R1441G mutant mice show no overt phenotype. However, synaptosomes from young (3-month-old) mutant mice exhibited lower DA uptake when incubated with rotenone (100nM), compared with wild-type controls. Number of tyrosine hydroxylase (TH)-positive neurons in mutant culture after rotenone exposure (5nM) was significantly lower. Also, chronic exposure to rotenone (5mg/kg, twice per week orally) for 20 weeks caused significantly lower locomotor activity in mutant mice compared with the wild-type controls. CONCLUSIONS: Similar to R1441C [1], LRRK2 R1441G mutant mice show no overt phenotype. However, R1441G mutant synaptosomes were more vulnerable to rotenone toxicity as shown by lower DA uptake, indicating that R1441G mutation contributes to mitochondrial dysfunction-induced synaptic dysfunction. Re-uptake of extracellular DA requires mitochondrial ATP for synaptic recycling. Uptake deficits associated with LRRK2 mutation may adversely affects striatal neuronal survival and locomotor activity as observed in our mutant mice. This differential susceptibility against rotenone toxicity of the mutant mice suggests that LRRK2 R1441G mutation may be a predisposing genetic factor in synaptic energy deficiency leading to early striatal synaptic dysfunction [2], and later nigrostriatal DA cell death in LRRK2-associated PD.-
dc.languageengen_US
dc.publisherJohn Wiley & Sons, Inc. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/76507419-
dc.relation.ispartofMovement Disordersen_US
dc.rightsMovement Disorders. Copyright © John Wiley & Sons, Inc.-
dc.subjectMedical sciences-
dc.subjectPsychiatry and neurology-
dc.titleLeucine-rich repeat kinase-2 (LRRK2) R1441G knockin mice are more susceptible to rotenone toxicityen_US
dc.typeConference_Paperen_US
dc.identifier.emailLiu, H: liuhf@hku.hken_US
dc.identifier.emailHo, WL: hwl2002@hku.hken_US
dc.identifier.emailTse, HM: zerotse@hku.hken_US
dc.identifier.emailKung, MHW: mhwkung@hkucc.hku.hken_US
dc.identifier.emailZhou, Z: zhongjun@hkucc.hku.hken_US
dc.identifier.emailHo, SL: slho@hku.hken_US
dc.identifier.authorityHo, WL=rp00259en_US
dc.identifier.authorityZhou, Z=rp00503en_US
dc.identifier.authorityHo, SL=rp00240en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1002/mds.25914-
dc.identifier.hkuros229825en_US
dc.identifier.volume29en_US
dc.identifier.issueS1-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats